There is increasing evidence of a connection between Parkinson's and the intestinal flora.

Here is the latest study on the subject:

In their study, the authors Izabela Oleksak, Michał Leśniewski, Iwona Welian-Polus, Karolina Maliszewska and Joanna Ziółkowska examined the possible connection between the intestinal microbiome and the development of Alzheimer's and Parkinson's disease. They used a literature review to analyze current findings and hypotheses published in medical databases such as PubMed and Google Scholar.

Research results:

It is noted that advances in the study of Alzheimer's and Parkinson's are related to the different progression and underlying mechanisms of both diseases. Various hypotheses are examined, including the role of inflammation, changes in intestinal flora, particularly the decrease in bacteria that produce short-chain fatty acids, and hygiene factors.

The authors emphasize the importance of the intestinal microbiome in the development and progression of Alzheimer's and Parkinson's disease. They note that both the gut microbiome and neurodegenerative diseases can be influenced by a variety of factors, including genetics, environmental factors and dietary habits.

The proposed treatment plans for Alzheimer's and Parkinson's are similar, and the authors suggest that early intervention, such as changing diet to a Mediterranean diet Nutrition, could reduce the risk of these diseases. In addition, the need for further research is emphasized to clarify the precise connections between the intestinal microbiome and the development of Alzheimer's and Parkinson's disease.

Summary:

copyrgh

3sat/nano/scobel/Ellen Haas/Claus Ast, CC BY 4.0, via Wikimedia Commons